INDP - Indaptus Therapeutics, Inc.
0.84
0.020 2.381%
Share volume: 6,258
Last Updated: 03-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.82
0.02
0.02%
Summary score
28%
Profitability
0%
Dept financing
32%
Liquidity
50%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2020 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-40.48%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
21.91%
Debt ratio change over timeo
0%
Current Ratio
4.67%
Quick Ratio
0%
Cash Position Ratio
4.48%
Short-term ratios 30-Sep-2023 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-40.48%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
21.91%
Debt ratio change over timeo
0%
Current Ratio
4.67%
Quick Ratio
0%
Cash Position Ratio
4.48%
Last quarter ratios 30-Sep-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-37.25%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
27.14%
Debt ratio change over time
0%
Current Ratio
3.42%
Quick Ratio
0%
Cash Position Ratio
3.31%
Performance ratios (change over 4 years) 30-Sep-2020 - 30-Sep-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | INDP | LLY | NVO | NONOF |
---|---|---|---|---|
Return on equity | 0% | 17.26% | 0% | 0% |
Return on assets | -40.48% | 4.16% | 0% | 0% |
Return on sales | 0% | 27.72% | 0% | 0% |
Return on invested capital | 0% | 9.99% | 0% | 0% |
Profitability | 0% | 100% | 0% | 0% |
Total debt ratio | 21.91% | 81.62% | 0% | 0% |
Debt ratio change over time | 0% | -14.38% | 0% | 0% |
Dept financing | 32% | 25% | 0% | 0% |
Current Ratio | 4.67% | 1.16% | 0% | 0% |
Quick Ratio | 0% | 0.89% | 0% | 0% |
Cash Position Ratio | 4.48% | 0.12% | 0% | 0% |
Liquididy | 50% | 32% | 0% | 0% |
Short-term ratios | INDP | LLY | NVO | NONOF |
---|---|---|---|---|
Return on equity | 0% | 18.92% | 0% | 0% |
Return on assets | -40.48% | 3.96% | 0% | 0% |
Return on sales | 0% | 27.19% | 0% | 0% |
Return on invested capital | 0% | 15.53% | 0% | 0% |
Profitability | 0% | 100% | 0% | 0% |
Total debt ratio | 21.91% | 81.43% | 0% | 0% |
Debt ratio change over time | 0% | -33.85% | 0% | 0% |
Dept financing | 32% | 25% | 0% | 0% |
Current Ratio | 4.67% | 1.16% | 0% | 0% |
Quick Ratio | 0% | 0.89% | 0% | 0% |
Cash Position Ratio | 4.48% | 0.12% | 0% | 0% |
Liquididy | 50% | 32% | 0% | 0% |